Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody directed against the alpha chain of the interleukin-5 receptor (CD125). It was...
5 KB (267 words) - 03:30, 20 April 2024
mepolizumab or reslizumab against IL-5, prevents eosinophilopoiesis, or benralizumab against IL-5 receptor, which eliminates eosinophils through ADCC antagonists...
28 KB (3,105 words) - 16:05, 11 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
56 KB (5,551 words) - 01:38, 26 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
31 KB (2,605 words) - 23:47, 9 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
41 KB (3,439 words) - 06:24, 28 July 2024
(IL-5) or its receptor (IL-5R), including mepolizumab, reslizumab or benralizumab, in addition to standard care in severe asthma is effective in reducing...
167 KB (18,025 words) - 04:35, 8 August 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
42 KB (3,794 words) - 23:03, 21 June 2024
drug is a human monoclonal antibody acting against tumors. The name of benralizumab, a drug designed for the treatment of asthma, has the components benra-li-zu-mab...
38 KB (3,088 words) - 05:02, 8 August 2024
Pascolizumab IL-5 Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:...
22 KB (1,789 words) - 04:29, 16 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
8 KB (967 words) - 07:52, 29 October 2022
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
20 KB (1,378 words) - 15:28, 5 August 2024
Pascolizumab IL-5 Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:...
31 KB (2,444 words) - 00:18, 6 August 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
16 KB (1,367 words) - 23:56, 10 July 2024
symptoms. Some examples of these drugs include mepolizumab, reslizumab, and benralizumab. Although eosinopenia has long been recognized as a laboratory marker...
15 KB (1,693 words) - 15:08, 25 April 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
31 KB (2,739 words) - 18:31, 9 August 2024
Pascolizumab IL-5 Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:...
22 KB (2,510 words) - 04:11, 12 August 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
33 KB (3,279 words) - 02:07, 3 August 2024
IL-4-specific blockers: Altrakincept Pascolizumab IL-5-specific blockers: Benralizumab Mepolizumab Reslizumab IL-13-specific blockers: Lebrikizumab Tralokinumab...
5 KB (560 words) - 00:25, 17 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
14 KB (718 words) - 14:56, 19 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
86 KB (7,929 words) - 11:30, 5 August 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
53 KB (4,941 words) - 09:29, 23 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
24 KB (2,153 words) - 23:56, 31 July 2024
(anti-PD-L1) tremelimumab (anti-CTLA-4) moxetumomab pasudotox (anti-CD22) benralizumab (anti-IL-5R) tralokinumab (anti-IL-13) anifrolumab (anti-IFN-aR) nirsevimab...
9 KB (800 words) - 00:48, 28 October 2023
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
16 KB (1,231 words) - 04:59, 4 February 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
87 KB (8,744 words) - 07:22, 30 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
22 KB (2,320 words) - 14:14, 7 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
10 KB (740 words) - 16:13, 20 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
44 KB (3,805 words) - 00:43, 23 July 2024
Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
216 KB (21,601 words) - 09:16, 19 July 2024
Pascolizumab IL-5 Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:...
15 KB (1,153 words) - 05:27, 18 July 2024